CalmiGo
CalmiGo

Drugs

Latest news

Life Biosciences in-licenses IP from new studies

Studies "open a new frontier in biotechnology and medicine," says Life Biosciences CEO. Intellectual property generated by the scientific findings behind two recent publications in...

Drusolv targets macular degeneration with statin therapy

Company seeks $2 million to prepare IND application for repurposed drug for AMD ahead of Phase 2 trials. Philadelphia-based start-up Drusolv Therapeutics is tackling age-related...

It’s time to sit up and take notice of mitochondria

CohBar CEO on the development of a “true portfolio” of mitochondria based therapeutics. US biotech company CohBar is developing mitochondria-based therapeutics for the treatment of...

Biotech Longeveron files for $30M IPO

Florida-based Longeveron files for a $30 million IPO, targeting aging-related conditions. Longeveron, a Phase 2 biotech which develops cellular therapies for aging-related conditions, filed the...

New Buck Institute study is treasure trove for longevity research

Compound that extends lifespan in worms also slows bone loss in mice. Scientists at the Buck Institute for Research on Aging conducted a longitudinal and functional study...

Proving the longevity potential of spermidine

Longevity Labs+ seeks to validate efficacy of spermidine supplement through clinical studies; aspires to become the Red Bull of longevity supplements. The home of famous...
Seno

You might also like

The Sheekey Science Show – Aging Clocks

Aging clocks - how to measure biological age. I hope you have some time on you hands as today we will talk all about aging...

Over a third of Generation X have multiple health problems

More than one in three British adults are suffering from two or more chronic health conditions in middle age, such as recurrent back problems,...

Forget the arms race – it’s time for a longevity race

Professor Andrew Scott outlines how society needs to change in order to capitalise on multi-trillion dollar longevity dividend. Last week, we brought you the views...

Taxi cab drivers aid dementia research in brain trial

UCL aims to help drive the fight against dementia by enlisting London's Black Cab drivers in a unique brain testing trial. London’s black cab drivers, famed...

Increased pace of aging in COVID-related mortality

Deep Longevity releases an AI-based predictor of COVID time-to-death. Deep Longevity, which is spearheading the provision of deep biomarkers of aging, has announced the publication...
Seno